Procter & Gamble (NYSE:PG) Given New $170.00 Price Target at Barclays

Procter & Gamble (NYSE:PG) had its target price boosted by Barclays from $168.00 to $170.00 in a research report report published on Tuesday morning, Benzinga reports. Barclays currently has an overweight rating on the stock.

Several other research firms have also recently issued reports on PG. Raymond James lifted their price objective on Procter & Gamble from $170.00 to $175.00 and gave the stock an outperform rating in a report on Wednesday, January 24th. JPMorgan Chase & Co. lowered their price objective on Procter & Gamble from $169.00 to $162.00 and set an overweight rating on the stock in a report on Thursday, January 18th. Stifel Nicolaus lifted their price objective on Procter & Gamble from $155.00 to $157.00 and gave the stock a hold rating in a report on Wednesday, January 24th. Truist Financial raised shares of Procter & Gamble from a hold rating to a buy rating and raised their target price for the stock from $160.00 to $175.00 in a research note on Monday, March 11th. Finally, Royal Bank of Canada raised their target price on shares of Procter & Gamble from $156.00 to $157.00 and gave the stock a sector perform rating in a research note on Wednesday, January 24th. Seven research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of Moderate Buy and a consensus target price of $168.88.

Procter & Gamble Price Performance

NYSE:PG opened at $161.50 on Tuesday. Procter & Gamble has a 52 week low of $141.45 and a 52 week high of $163.14. The company has a quick ratio of 0.48, a current ratio of 0.69 and a debt-to-equity ratio of 0.48. The stock has a market capitalization of $380.01 billion, a PE ratio of 26.39, a price-to-earnings-growth ratio of 3.19 and a beta of 0.44. The stock’s 50-day moving average price is $159.32 and its 200-day moving average price is $153.26.

Procter & Gamble (NYSE:PG) last posted its quarterly earnings data on Friday, April 19th. The company reported $1.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.42 by $0.10. Procter & Gamble had a return on equity of 33.77% and a net margin of 18.00%. The company had revenue of $20.20 billion for the quarter, compared to analysts’ expectations of $20.43 billion. During the same period in the previous year, the firm posted $1.37 EPS. Procter & Gamble’s revenue was up .6% compared to the same quarter last year. As a group, equities analysts expect that Procter & Gamble will post 6.53 EPS for the current fiscal year.

Procter & Gamble Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th will be given a $1.0065 dividend. This is a positive change from Procter & Gamble’s previous quarterly dividend of $0.94. The ex-dividend date is Thursday, April 18th. This represents a $4.03 dividend on an annualized basis and a yield of 2.49%. Procter & Gamble’s payout ratio is presently 65.69%.

Insider Buying and Selling at Procter & Gamble

In other Procter & Gamble news, COO Shailesh Jejurikar sold 31,275 shares of the business’s stock in a transaction that occurred on Thursday, January 25th. The stock was sold at an average price of $154.90, for a total value of $4,844,497.50. Following the sale, the chief operating officer now owns 9,623 shares of the company’s stock, valued at $1,490,602.70. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other Procter & Gamble news, CEO R. Alexandra Keith sold 855 shares of the stock in a transaction dated Monday, April 22nd. The stock was sold at an average price of $158.50, for a total value of $135,517.50. Following the sale, the chief executive officer now owns 4,004 shares of the company’s stock, valued at approximately $634,634. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, COO Shailesh Jejurikar sold 31,275 shares of the stock in a transaction dated Thursday, January 25th. The shares were sold at an average price of $154.90, for a total value of $4,844,497.50. Following the completion of the sale, the chief operating officer now directly owns 9,623 shares in the company, valued at approximately $1,490,602.70. The disclosure for this sale can be found here. Insiders have sold a total of 103,771 shares of company stock valued at $16,292,467 over the last quarter. 0.17% of the stock is owned by company insiders.

Institutional Investors Weigh In On Procter & Gamble

A number of hedge funds have recently bought and sold shares of the stock. Cardinal Capital Management raised its position in shares of Procter & Gamble by 1.0% during the 3rd quarter. Cardinal Capital Management now owns 48,489 shares of the company’s stock worth $7,073,000 after acquiring an additional 494 shares in the last quarter. Altus Wealth Management LLC raised its position in shares of Procter & Gamble by 0.5% during the 3rd quarter. Altus Wealth Management LLC now owns 30,579 shares of the company’s stock worth $4,460,000 after acquiring an additional 144 shares in the last quarter. First Affirmative Financial Network raised its position in shares of Procter & Gamble by 21.3% during the 3rd quarter. First Affirmative Financial Network now owns 5,103 shares of the company’s stock worth $744,000 after acquiring an additional 895 shares in the last quarter. Bridge Creek Capital Management LLC raised its position in shares of Procter & Gamble by 1.0% during the 3rd quarter. Bridge Creek Capital Management LLC now owns 42,367 shares of the company’s stock worth $6,180,000 after acquiring an additional 437 shares in the last quarter. Finally, Buttonwood Financial Advisors Inc. raised its position in shares of Procter & Gamble by 3.4% during the 3rd quarter. Buttonwood Financial Advisors Inc. now owns 9,765 shares of the company’s stock worth $1,424,000 after acquiring an additional 322 shares in the last quarter. Institutional investors and hedge funds own 65.77% of the company’s stock.

About Procter & Gamble

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.